The PE is rich in the mid-50s, but has 20% revenue growth, and they have a revolutionary medical device, an insulin patch. Have a new CEO.
Stock price when the opinion was issued
Build your watch list
Sign in to track investmentsyou care about
Harvest Portfolios Group
Stockchase Premium
ETF Capital Management Inc.
Murray Wealth Group
5i Research
The PE is rich in the mid-50s, but has 20% revenue growth, and they have a revolutionary medical device, an insulin patch. Have a new CEO.